Danazol inhibits human adrenal 21-and 11β-hydroxylation invitro
article
OA: closed
CC0
⤵ 12 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Danazol was found to inhibit human adrenal 21- and 11β-hydroxylase enzymes in vitro.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- Adrenal Function During Chronic Danazol Administration via openalex
- A radioimmumoassay for danazol (17α-Pregna-2,4-Dien-20-Yno[2,3-d]Isoxazol-17-OL) via openalex
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol Inhibits Steroidogenesis in the Rat Testis<i>in Vitro</i> via openalex
- Hormonal changes associated with Danazol therapy. via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- The use of an impeded androgen—danazol—in the management of benign breast disorders via openalex
- doi:10.1042/bj0261406 via openalex
- doi:10.1016/0024-3205(75)90208-8 via openalex
- doi:10.1210/endo-99-4-1097 via openalex
- doi:10.1016/s0021-9258(19)52451-6 via openalex
- doi:10.1210/jcem-35-4-522 via openalex
- doi:10.1507/endocrj1954.25.191 via openalex
- doi:10.1016/s0015-0282(16)41231-8 via openalex
- doi:10.1210/jcem-26-10-1144 via openalex
- doi:10.1210/endo-69-2-354 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1021/ja01318a036 via openalex
Cited by (12)
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- In utero virilization by danazol: Effects on adrenal steroidogenesis 1995
- Ambiguedad sexual por exposición a DANAZOL 1992
- The use of danazol as a treatment of endometriosis 1991
- Comparison of the pharmacology of nafarelin and danazol 1990
- Inhibition of gonadotropin-releasing hormone receptors in rat anterior pituitary monolayer cell cultures by danazol 1986
- Effects of danazol on steroidogenesis and gonadotropic responsiveness in isolated human preovulatory follicular cells 1986
- Danazol 1982
- Danazol 1982
- Actions of danazol in vivo on cytochrome P-450 and steroidogenic enzymes in rat testis and liver microsomal preparations 1981
- Transient Adrenogenital Syndrome due to Exposure to Danazol in Utero 1981
- Inhibition of Adrenal Steroidogenesis by Danazol in Vivo 1980
Source provenance
- openalex
- last seen: 2026-05-10T10:32:10.358136+00:00
License: CC0
· commercial use OK